low blood sugar with semaglutide Type 1 on a GLP-1 Drug? Watch for Hypoglycemia and DKA Semaglutide (Ozempic, Wegovy, Rybelsus) -

November 1, 2024: Physicians Warn People Taking Ozempic of Skeletal Muscle Mass Loss and Call for More Research Recent commentary published in JAMA warns that skeletal muscle mass (SMM) experienced while taking GLP-1 drugs may be of medical concern

Unlike commercially manufactured medications, compounded semaglutide is not FDA-regulated

Why patience is important Semaglutide is intended for long-term use

No jury trial or settlement has occurred in either jurisdiction, but the FDA now required an addendum be included with the Ozempic warning label, citing intestinal blockage and obstruction as a potential side effect

Regular Exercise Physical activity increases insulin sensitivity and improves appetite control